Published on January 03, 2024. EST READ TIME: 2 minutes
The cases of COVID-19 continue to rise across India, along with respiratory illness and other winter allergies. The surge, driven by the JN.1 COVID-19 variant, has led to a 22 per cent rise in COVID-19 cases in the country in the last week of 2023. Hospitals, especially the chest and pulmonary wards, are working at full capacity. However, amidst this rise in the number of COVID-19 cases, experts are facing a new challenge.
It has now come to light that the new JN.1 virus has two new symptoms in addition to the symptoms reported before by COVID-19 patients. According to the UK’s Office for National Statistics, some infected people have said that they have experienced trouble sleeping and anxiety, along with runny noses, coughs, headaches, and weakness.
According to data, the most common Covid-19 symptoms are runny nose (31.1 per cent), cough (22.9 per cent), headache (20.1 per cent), fatigue (19.6 per cent), muscle pain (15.8 per cent), sore throat (13.2 per cent), trouble sleeping (10.8 per cent), and anxiety (10.5 per cent). The Centres for Disease Control and Prevention previously warned that the JN.1 strain of the virus is flourishing in the UK and the US, Iceland, Portugal, and Spain. Now, the virus is showing its ugly presence, which is felt rapidly in France, China, and India.